Mellem 79 og 89% af kolorektalkræfttyper og over 90% af pladecellekræfttyper i hoved- hals- regionen har EGFR på celleoverfladen.
Between 79 and 89% of colorectal cancers and more than 90% of squamous cell cancers of the head and neck have EGFR on the cell surface.